NRTH — 48North Cannabis Share Price
Last Trade - 00:00- CA$23.66m
- CA$27.33m
- CA$8.72m
Momentum
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | |||
| EPS Growth (f) | |||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | |||
| Price to Tang. Book | |||
| Price to Free Cashflow | |||
| Price to Sales | |||
| EV to EBITDA | |||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | |||
| Return on Equity | |||
| Operating Margin | |||
Financial Summary
| Year End 30th Jun | Unit | 2016 | 2017 | 2018 | 2019 | 2020 | 2021E | 2022E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CA$m | n/a | n/a | n/a | 4.82 | 8.72 | 39.6 | 36.3 | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Health trend(F-Score)
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
48North Cannabis Corp is a Canada-based company, which manufactures cannabis-based products for medical purposes. The Company's subsidiary, DelShen Therapeutics, is a licensed producer of medical cannabis in Canada. 48North Cannabis Corp grows genetics sourced from MariPharm BV, a Netherlands-based phytopharmaceutical company engaged in the research and cultivation of cannabis for medical purposes. DelShen Therapeutics is regulated by the Access to Cannabis for Medical Purposes Regulations (ACMPR) and the facility is located on an approximately 800-acres of owned land near Kirkland Lake, Ontario, Canada. DelShen Therapeutics operates in an approximately 40,000-square-foot closed-box facility, which produces more than 2,000 kilograms of cannabis annually.
Directors
- Martin Cauchon
- Charles Vennat
- Alison Gordon CCE
- Jeannette Vandermarel CCE
- David Hackett
- Kevin Helfand
- Kirsten Gauthier
- Anne Darche
- Susan Nickle
- William Assini
- Alain Dubuc
- James Gervais
- Last Annual
- June 30th, 2020
- Last Interim
- March 31st, 2021
- Incorporated
- January 1st, 2013
- Public Since
- May 18th, 2011
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- TSX Venture Exchange
- Shares in Issue
- 225,312,227
- Address
- 257 Adelaide Street West, Suite 500, Toronto, M5H 1X9
- Web
- https://48nrth.com/en/
- Phone
- +1 4166395891
- Auditors
- MNP LLP
Latest News for NRTH
Upcoming events for NRTH
Similar to NRTH
CANADABIS CAPITAL ORD
TSX Venture Exchange
CANNARA BIOTECH ORD
TSX Venture Exchange
CITIZEN STASH CANNAB ORD
TSX Venture Exchange
DECIBEL CANNABIS COM ORD
TSX Venture Exchange
EASTWOOD BIO MEDICAL CANADA ORD
TSX Venture Exchange
FAQ
As of Today at 11:30 UTC, shares in 48North Cannabis are trading at CA$0.11. This share price information is delayed by 15 minutes.
Shares in 48North Cannabis last closed at CA$0.11 and the price had moved by -44.44% over the past 365 days. In terms of relative price strength the 48North Cannabis share price has underperformed the Toronto Stock Exchange 300 Composite Index by -54.98% over the past year.
The overall consensus recommendation for 48North Cannabis is Hold. You can view the full broker recommendation list by unlocking its StockReport.
48North Cannabis does not currently pay a dividend.
48North Cannabis does not currently pay a dividend.
48North Cannabis does not currently pay a dividend.
To buy shares in 48North Cannabis you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of CA$0.11, shares in 48North Cannabis had a market capitalisation of CA$23.66m.
Here are the trading details for 48North Cannabis:
- Country of listing: Canada
- Exchange: CVE
- Ticker Symbol: NRTH
Based on an overall assessment of its quality, value and momentum 48North Cannabis is currently classified as a Value Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in 48North Cannabis is CA$0.35. That is 233.33% above the last closing price of CA$0.11.
Analysts covering 48North Cannabis currently have a consensus Earnings Per Share (EPS) forecast of for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like 48North Cannabis. Over the past six months, its share price has underperformed the Toronto Stock Exchange 300 Composite Index by -71.56%.
As of the last closing price of CA$0.11, shares in 48North Cannabis were trading -42.2% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
We are not able to find PE ratio data for 48North Cannabis.
48North Cannabis' management team is headed by:
- Martin Cauchon -
- Charles Vennat -
- Alison Gordon - CCE
- Jeannette Vandermarel - CCE
- David Hackett -
- Kevin Helfand -
- Kirsten Gauthier -
- Anne Darche -
- Susan Nickle -
- William Assini -
- Alain Dubuc -
- James Gervais -
We do not have data on 48North Cannabis' shareholders